BPC-157 has been studied for a variety of topics and has shown to be helpful in many areas such as: tendinopathy, gastric ulcers, general inflammation, and even neuroprotection
Any company that aspires to prove the safety and effectiveness of a peptide will turn away from them, knowing that compounders will simply be able to sell them without ever needing to generate safety and effectiveness evidence. Indeed, Lurie continued, financial analysts are predicting a $2.2 billion telehealth marketing opportunity if these peptides are approved for compounding
There are lots of things that happen to us, but there are things that we control, such as our diet
Some panelists, many with connections to the peptide industry, argue that the approval of these peptides will help to shut down or limit the gray market, as RFK Jr